logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
PE/iFluor® 594 Anti-human CD38 Antibody
HIT2
HIT2 is an anti-human monoclonal antibody that targets the CD38 antigen. CD38 (alternatively called T10) is a 45 kD transmembrane protein that is found on the surface of cells such as NK cells, macrophages and stem cells. CD38 is a component of vital cellular pathways, namely, the apoptotic signaling pathway and B cell receptor signaling pathway. In addition, in certain organisms, it represses apoptotic process, is a positive regulator of cell growth and is an enhancer of vasoconstriction. From a research standpoint, it is of biological interest due to its association with critical macromolecules/ligands like HLA Class II, CD31, CD16 and Hyaluronic acid. CD38 is a fairly uncommon antibody target, with a little more than 10000 publications in the last decade. Even still, CD38 has been widely used in immunology research, commonly serving as a phenotypic marker for differentiating cell types in flow cytometric applications. This antibody was purified through affinity chromatography and conjugated to PE/iFluor® 594 (ex/em = 566/606 nm). It is compatible with the 561 nm laser and 610/20 nm bandpass filter (for example, as in the BD FACSCelesta™).
product image
product image
CatalogSize
Price
Quantity
103801Y025 tests
Price
103801Y1100 tests
Price
103801Y2500 tests
Price
 
Antibody properties

Other namesADP-ribosyl cyclase; T10
CloneHIT2
Hostmouse
Isotypemouse IgG1
Reactivityhuman
Spectral properties

Absorbance (nm)566
Extinction coefficient (cm -1 M -1)
1960000
Excitation (nm)565
Emission (nm)606
Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on October 8, 2025